Experimental coronavirus treatment leronlimab has delivered “strong results” in the treatment of COVID-19 patients, according to developer CytoDyn. The drug also has been attracting attention as a potential coronavirus treatment, particularly to quell the so-called “cytokine storm,” when COVID-19 has caused the immune system to go awry. EXPERIMENTAL CORONAVIRUS TREATMENT LERONLIMAB HAS DELIVERED 'IMPRESSIVE' EARLY RESULTS, DEVELOPER SAYSSome 49 COVID-19 patients have been treated with leronlimab under the program, according to CytoDyn’s statement, including 11 patients in a New York hospital. All of the treated patients were in intensive care because of acute respiratory failure and eight had been placed on mechanical ventilation. “Despite their pre-existing and severe conditions, we believe we were able to save the lives of four patients,” CytoDyn said.

Source: Fox News May 01, 2020 13:07 UTC